NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
26 April 2025
| Name: | SIGMA HEALTHCARE LIMITED (SIG) | ||||||||||||
| ISIN: | AU000000SIG5 | ||||||||||||
| Date of Listing: | 30 October 2002 | ||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 088 417 403ABN: 15 088 417 403
Registration Date: 02 July 1999
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| SIGMA HEALTHCARE LIMITED | 08/05/2017 | |
| SIGMA PHARMACEUTICALS LIMITED | 04/05/2017 | 08/05/2017 |
| SIGMA PHARMACEUTICALS LIMITED | 13/12/2005 | 04/05/2017 |
| ARROW PHARMACEUTICALS LIMITED | 13/12/2005 |
Link Market Services Melbourne
Tower 4, 727 Collins Street Docklands VIC 3008
Tel : +61 3 9615 9800 or 61 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
Expand this box to read and print
The suspension of trading in the securities of Sigma Healthcare Limited will be lifted immediately following the release by SIG of an announcement regarding a capital raising. | 13/12/2023 |
The Company announces the successful completion of the institutional component of its fully underwritten 1 for 1.85 prorata accelerated non-renounceable entitlement offer to raise approximately $400 million. The Institutional Entitlement Offer raised approximately $178 million and was strongly supported by existing eligible institutional shareholders. Take-up by existing eligible institutional shareholders under the Institutional Entitlement Offer and by HMC Capital Limited, the manager of Sigma's largest shareholder, HMC Capital Partners Fund I is 92%. The retail component of the Entitlement Offer, which is fully underwritten, will raise a further approximately $223 million. The Retail Entitlement Offer will open 9:00am (Melbourne Time) on Monday, 18 December 2023 and close 5:00pm (Melbourne Time) on Friday, 19 January 2024. | 13/12/2023 |
The company releases a notice of proposed issue of securities. | 11/12/2023 |
The Company will hold a briefing on its proposed merger and equity raise briefing at 10.30am AEDT, 11 December 2023 via webcast through this link: https://edge.media-server.com/mmc/p/uy6cy3fk. | 11/12/2023 |
The Company releases a Cleansing Notice for the underwritten pro rata accelerated non-renounceable entitlement offer. | 11/12/2023 |
The company lodges the following: CW Group Holdings Ltd FY21, FY22 and FY23 Audited Financial Statements. | 11/12/2023 |
The company releases an Investor Presentation on its Merger & Equity Raising. | 11/12/2023 |
Transformational merger between Sigma and CWG to create a leading healthcare wholesaler, distributor and retail pharmacy franchisor. CWG is a leading Australian retail pharmacy franchisor, supporting a multi-national Retail Network of ~600 stores, mainly operating under the highly recognised Chemist Warehouse brand. Sigma is a major Australian pharmaceutical wholesaler and pharmacy franchisor. Proposed Merger to be effected by Sigma acquiring CWG via a scheme of arrangement in exchange for Sigma shares and $700 million cash consideration. CWG shareholders to hold 85.75% and Sigma shareholders to hold 14.25% of the merged group upon completion of the Proposed Merger. | 11/12/2023 |
The securities of Sigma Healthcare Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SIG, pending the release of an announcement regarding a material transaction. | 08/12/2023 |
name changed from Sigma Pharmaceuticals Limited | 08/05/2017 |
The suspension of trading in the securities of Sigma Healthcare Limited will be lifted immediately following the release by SIG of an announcement regarding a capital raising. | 13/12/2023 |
The Company announces the successful completion of the institutional component of its fully underwritten 1 for 1.85 prorata accelerated non-renounceable entitlement offer to raise approximately $400 million. The Institutional Entitlement Offer raised approximately $178 million and was strongly supported by existing eligible institutional shareholders. Take-up by existing eligible institutional shareholders under the Institutional Entitlement Offer and by HMC Capital Limited, the manager of Sigma's largest shareholder, HMC Capital Partners Fund I is 92%. The retail component of the Entitlement Offer, which is fully underwritten, will raise a further approximately $223 million. The Retail Entitlement Offer will open 9:00am (Melbourne Time) on Monday, 18 December 2023 and close 5:00pm (Melbourne Time) on Friday, 19 January 2024. | 13/12/2023 |
The company releases a notice of proposed issue of securities. | 11/12/2023 |
The Company will hold a briefing on its proposed merger and equity raise briefing at 10.30am AEDT, 11 December 2023 via webcast through this link: https://edge.media-server.com/mmc/p/uy6cy3fk. | 11/12/2023 |
The Company releases a Cleansing Notice for the underwritten pro rata accelerated non-renounceable entitlement offer. | 11/12/2023 |
The company lodges the following: CW Group Holdings Ltd FY21, FY22 and FY23 Audited Financial Statements. | 11/12/2023 |
The company releases an Investor Presentation on its Merger & Equity Raising. | 11/12/2023 |
Transformational merger between Sigma and CWG to create a leading healthcare wholesaler, distributor and retail pharmacy franchisor. CWG is a leading Australian retail pharmacy franchisor, supporting a multi-national Retail Network of ~600 stores, mainly operating under the highly recognised Chemist Warehouse brand. Sigma is a major Australian pharmaceutical wholesaler and pharmacy franchisor. Proposed Merger to be effected by Sigma acquiring CWG via a scheme of arrangement in exchange for Sigma shares and $700 million cash consideration. CWG shareholders to hold 85.75% and Sigma shareholders to hold 14.25% of the merged group upon completion of the Proposed Merger. | 11/12/2023 |
The securities of Sigma Healthcare Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of SIG, pending the release of an announcement regarding a material transaction. | 08/12/2023 |
name changed from Sigma Pharmaceuticals Limited | 08/05/2017 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 14/02/2025 | Vikesh Ramsunder | -11,662,028 | $2.920 | $34,053,122 |
| 16/05/2022 | Kate Spargo | 120,000 | $0.463 | $55,500 |
| 07/04/2022 | Christine Bartlett | 60,000 | $0.483 | $28,950 |
| 30/09/2020 | Mark Hooper | 250,000 | $0.561 | $140,127 |
| 22/09/2020 | Mark Hooper | 500,000 | $0.589 | $294,476 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Vikesh Ramsunder | Managing Director, CEO | 01/02/2022 |
| Mark Conway | CFO | 01/11/2023 |
| Christopher Roberts | Non Exec Director | 06/10/2023 |
| Neville Mitchell | Non Exec Director | 02/02/2023 |
| Annette Carey | Non Exec Director | 02/02/2023 |
| Michael Sammells | Interim Chairman | 01/02/2020 |
| Jack Gance | Director | 12/02/2025 |
| Mario Verrocchi | Director | 12/02/2025 |
| Damien Gance | Director | 12/02/2025 |
| Danielle Di Pilla | Director | 12/02/2025 |
| Kara McGowan | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Kate Spargo | Independent Director | 09/12/2015 | 12/02/2025 |
| Christine Bartlett | Independent Director | 30/03/2016 | 07/12/2023 |
| Gary Woodford | CFO | 01/09/2023 | 01/11/2023 |
| Nigel Simonsz | CFO | 29/08/2022 | 16/06/2023 |
| David Manuel | Non Exec Director | 26/10/2009 | 17/05/2023 |
| Josephine De Martino | CFO | 11/04/2022 | 29/08/2022 |
| Ray Gunston | Chairman | 01/10/2009 | 06/07/2022 |
| Jeff Sells | CFO | 01/08/2010 | 11/04/2022 |
| Mark Hooper | CEO | 30/08/2010 | 31/12/2021 |
| Jackie Pearson | CFO | 30/09/2020 | 18/11/2021 |
| David Bayes | Non Exec Director | 25/06/2007 | 14/05/2021 |
| Wayne Johnston | CFO | 30/03/2020 | 26/06/2020 |
| Brian Jamieson | Non Exec Chairman | 05/12/2005 | 13/05/2020 |
| Iona MacPherson | CFO | 02/11/2016 | 08/01/2020 |
| Linda Nicholls | Non Exec Director | 05/12/2005 | 09/12/2015 |
| William Scott | Non Exec Director | 05/12/2005 | 08/06/2011 |
| Elmo Alwis | Managing Director, CEO | 05/12/2005 | 13/08/2010 |
| John Stocker | Non Exec Chairman | 05/12/2005 | 21/06/2010 |
| Doug Curlewis | Director | 25/06/2007 | 21/06/2010 |
| David Mortimer | Non Exec Director | 18/11/2002 | 01/07/2007 |
| David Duchen | Non Exec Director | 03/12/1999 | 16/05/2007 |
| Paul Duchen | Managing Director | 06/12/2005 | |
| Paul Williams | Executive | 06/12/2005 | |
| Con Tangalakis | Executive | 06/12/2005 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
